Similar benefits were observed for other markers of the ageing process including lipid peroxides and protein oxidation due to the combination supplement
It is important to note that all three studies were performed by the same group so there is not independent confirmation of the effectiveness of ALC , although I can certainly share some anecdotes from women who have used it after examining this evidence (in another post cause this one is already a monster!!)
| Protocol Type | Tirzepatide Dose | 5-Amino-1MQ Dose | Administration Frequency | Expected Mechanism | Typical Observation Window | Professional Assessment | ||||||| | Tirzepatide Monotherapy | 2.515mg weekly (titrated) | None | Weekly subcutaneous injection | GLP-1/GIP receptor agonism reduces appetite and slows gastric emptying | 1220 weeks to plateau | Proven efficacy in human trials
Unlike broad growth hormone therapies, Tesamorelin is highly targeted, it is best known for its ability to reduce visceral fat, the deep abdominal fat that surrounds internal organs and is strongly linked to metabolic disease
Eli Lillys retatrutide , a triple GIP/GLP-1/glucagon agonist, showed 28.7% weight loss in Phase 3 (December 2025 results) and may be submitted to FDA in late 2026
.png)
